135 related articles for article (PubMed ID: 19487543)
41. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
42. [Clinical significance of serum proteomic profiling before and after cervical cancer surgery].
Shao ZY; Zheng ZG; Lou HM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):374-8. PubMed ID: 19573315
[TBL] [Abstract][Full Text] [Related]
43. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
44. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
45. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
[TBL] [Abstract][Full Text] [Related]
46. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
[TBL] [Abstract][Full Text] [Related]
47. MALDI-TOF serum protein profiling for the detection of breast cancer.
de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
[TBL] [Abstract][Full Text] [Related]
48. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis of breast cancer by tear proteomic pattern.
Lebrecht A; Boehm D; Schmidt M; Koelbl H; Schwirz RL; Grus FH
Cancer Genomics Proteomics; 2009; 6(3):177-82. PubMed ID: 19487546
[TBL] [Abstract][Full Text] [Related]
50. Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.
Belluco C; Petricoin EF; Mammano E; Facchiano F; Ross-Rucker S; Nitti D; Di Maggio C; Liu C; Lise M; Liotta LA; Whiteley G
Ann Surg Oncol; 2007 Sep; 14(9):2470-6. PubMed ID: 17594124
[TBL] [Abstract][Full Text] [Related]
51. Proteomic profiling to identify prognostic biomarkers in heart failure.
Scott PA; Zeidan B; Ng LL; Zeb M; Rosengarten JA; Garbis S; Curzen NP; Morgan JM; Townsend PA
In Vivo; 2012; 26(6):875-82. PubMed ID: 23160667
[TBL] [Abstract][Full Text] [Related]
52. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
53. Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.
Zamani-Ahmadmahmudi M; Nassiri SM; Rahbarghazi R
Electrophoresis; 2014 Mar; 35(6):901-10. PubMed ID: 24338489
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer classification by proteomic technologies: current state of knowledge.
Lam SW; Jimenez CR; Boven E
Cancer Treat Rev; 2014 Feb; 40(1):129-38. PubMed ID: 23891266
[TBL] [Abstract][Full Text] [Related]
55. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
56. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ; Lovell MO; Izbicka E
Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
[TBL] [Abstract][Full Text] [Related]
57. A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer.
Fry SA; Sinclair J; Timms JF; Leathem AJ; Dwek MV
Cancer Lett; 2013 Jan; 328(2):335-44. PubMed ID: 23079531
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling.
Albrethsen J; Kaas A; Schönle E; Swift P; Kocova M; Gammeltoft S; Hansen L; Mortensen HB
Proteomics Clin Appl; 2009 Mar; 3(3):383-93. PubMed ID: 22275309
[TBL] [Abstract][Full Text] [Related]
59. Serum proteomics for biomarker discovery in nonalcoholic fatty liver disease.
Yilmaz Y
Clin Chim Acta; 2012 Aug; 413(15-16):1190-3. PubMed ID: 22546610
[TBL] [Abstract][Full Text] [Related]
60. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
